Synchronized changes in serum vascular endothelial growth factor during the clinical course of chronic systemic capillary leak syndrome

Internal Medicine

Volumn 49, Issue 8, 2010, Pages 791-794

  Kinoshita, Yoshiaki ^a   Kasaoka, Shunji ^a   Fujita, Motoki ^a   Oshima, Chiyomi ^a   Kawamura, Yoshikatsu ^a   Tsuruta, Ryosuke ^a   Maekawa, Tsuyoshi ^a  

^a YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Prednisolone; Systemic capillary leak syndrome; Terbutaline; Theophylline; Vascular endothelial growth factor

Indexed keywords

ALBUMIN; PREDNISOLONE; TERBUTALINE; THEOPHYLLINE; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CAPILLARY LEAK SYNDROME; CASE REPORT; CLINICAL EXAMINATION; CONVALESCENCE; DEHYDRATION; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; EDEMA; FLUID THERAPY; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; MALE; URINE VOLUME;

BIOLOGICAL MARKERS; CAPILLARY LEAK SYNDROME; CHRONIC DISEASE; HUMANS; MALE; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTORS; YOUNG ADULT;

EID: 77951224240     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2929     Document Type: Article

References (16)

1. Clarkson B, Thompson D, Horwith M, Luckey EH. Cyclical edema and shock due to increased capillary permeability. Am J Med 29: 193-216, 1960.
2. Droder RM, Kyle RA, Greipp PR. Control of systemic capillary leak syndrome with aminophylline and terbutaline. Am J Med 92: 523-526, 1992.
3. Tahirkheli NK, Greipp PR. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. Ann Intern Med 130: 905-909, 1999.
4. Manfred I, Oliver S, Peter K, Sibylle G, Wolfgang E, Daniela G. Vascular endothelial growth factor serum level is strongly enhanced after burn injury and correlated with local and general tissue edema. Burns 30: 305-311, 2004.
5. Murata H, Yoshimoto H, Ryu T, et al. High fever, renal failure, disseminated intravascular coagulation and myelodysplasia accompanied with enhanced angiogenesis possibly due to overexpression of vascular endothelial growth factor. Intern Med 39: 570-575, 2000.
6. Airaghi L, Montori D, Santambrogio L, Miadonna A, Tedeschi A. Chronic systemic capillary leak syndrome. Report of a case and review of the literature. J Intern Med 247: 731-735, 2000.
7. Rauzy O, Adoue D, Arlet P. Chronic systemic capillary leak syndrome not requiring treatment? Am J Med 105: 360, 1998.
8. Atkinson JP, Waldmann TA, Stein SF, et al. Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore) 56: 225-239, 1977.
9. Lesterhuis WJ, Rennings AJ, Leenders WP, et al. Vascular endothelial growth factor in systemic capillary leak syndrome. Am J Med 122: e5-e7, 2009.
10. Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 23: 1051-1056, 2000.
11. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985, 1983.
12. Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39: 225-237, 2002.
13. Hippenstiel S, Krüll M, Ikemann A, Risau W, Clauss M, Suttorp N. VEGF induces hyperpermeability by a direct action on endothelial cells. Am J Physiol 274: 678-684, 1998.
14. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108: 2369-2379, 1995.
15. Rissanen TT, Vajanto I, Hiltunen MO, et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol 160: 1393-1403, 2002.
16. Iacobellis G, Cipriani R, Gabriele A, Di Mario U, Morano S. High circulating vascular endothelial growth factor (VEGF) is related to a better systolic function in diabetic hypertensive patients. Cytokine 27: 25-30, 2004.